Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-29

Clinical Trial Update: A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial of a botanical drug containing East Indian Sandalwood Oil for atopic dermatitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • East Indian Sandalwood Oil (EISO) botanical drug (East Indian Sandalwood Oil)

Snippet

Sponsor: Santalis Pharmaceuticals, Inc. | Conditions: Atopic Dermatitis, Eczema | Phase 2 | Status: COMPLETED | Results posted: 2019-05-29